Al Hammadi Company for Development and Investment (4007.SE)

Also known as:  Al Hammadi
Data delayed by 15 minutes
25.90 SAR 0.803.19%
As of 28 JUL 2020 12:19 GMT|Saudi SE

Al Hammadi Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
-
P/E (Last 12 Month)
32.63
Upside
-
Target Price (Mean)
-
52Wk
16.66 23 MAR
26.1 23 FEB

Open
25.00 SAR
Previous Close
25.90 SAR
Turnover
19.39M SAR
EPS
0.781 SAR
Volume
759,404
Transactions
924
Market Cap
3.11B SAR
IPO Date
14-Jul-2014
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Al Hammadi Company for Development and InvestmentLast updated on: 31 March 2020

Business Summary
Ownership, operation and management of general hospitals; distribution of medical equipment, medical supplies and pharmaceuticals.
Country of Incorporation
Ownership Type
Established In
1985
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
4007.SSEOrdinarySARSaudi SE4007

Contact details

Primary address
Al Hammadi Hospital - Al Olaya Building
Al Oruba Street
Al Olaya District
55004
Saudi Arabia
Riyadh
11534
CONTACT
Region
Riyadh
More

There may never be a 'silver bullet' for COVID-19: WHO

Despite vaccines in development, the head of the World Health Organization cautioned that the treatments had yet to prove effective and might only convey protection for a short time. This report produced by Zachary Goelman.

Reuters Videos - Monday 3 August 2020
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Executives

Mr Mohammed Saleh Mohammed Al Hammadi
Chief Executive Officer and Managing Director
Mr Mohammed Said Suleiman Al Saafeen
Chief Financial Officer
Dr Abdulaziz Saleh Mohammed Hamad Al Hammadi
Chief Operating Officer

Board Members

Mr Saleh Mohammed Hamad Al Hammadi
Chairman
Dr Abdulaziz Mohammed Hamad Al Hammadi
Vice Chairman
Dr Sami Abdullah Dakheilallah Al Said
Director
More

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
MOUWASAT MED SEV109.000 SAR5.21
PHARMACEUTICALS31.350 SAR0.64
SAUDI GERMAN HSP33.000 SAR1.38
SULAIMAN ALHABIB88.000 SAR0.57
DALLAH HEALTH54.000 SAR1.89
More

Tuesday Outlook: Asian stocks advance; gold near record high as virus risks remain

Tuesday Outlook: Asian stocks advance; gold near record high as virus risks remain

Dollar's August bounce retraces slightly; oil gives up gains on expected output increase

More

Most Viewed Stocks

Stock Screener

More